Two Compounds Commonly Used for Phospholipase C Inhibition Activate the Nuclear Estrogen Receptors
- 1 August 1999
- journal article
- Published by Elsevier in Biochemical and Biophysical Research Communications
- Vol. 261 (2) , 340-344
- https://doi.org/10.1006/bbrc.1999.1017
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Ligand-independent Activation of Steroid Receptors: New Roles for Old PlayersTrends in Endocrinology & Metabolism, 1999
- Evidence for separate effects of U73122 on phospholipase C and calcium channels in human plateletsBiochemical Pharmacology, 1998
- Environmental estrogens and breast cancer riskCurrent Opinion in Oncology, 1998
- Co-activators and co-repressors in the integration of transcriptional responsesCurrent Opinion in Cell Biology, 1998
- U73122 and U73343 inhibit receptor-mediated phospholipase D activation downstream of phospholipase C in CHO cellsEuropean Journal of Pharmacology, 1998
- Determinants of Ligand Specificity of Estrogen Receptor-α: Estrogen versus Androgen DiscriminationJournal of Biological Chemistry, 1998
- Regulation of Phosphoinositide-specific Phospholipase C IsozymesJournal of Biological Chemistry, 1997
- Comparison of the Ligand Binding Specificity and Transcript Tissue Distribution of Estrogen Receptors α and βEndocrinology, 1997
- The nuclear receptor superfamily: The second decadeCell, 1995
- U73122 inhibits phospholipase C-dependent calcium mobilization in neuronal cellsBrain Research, 1994